Customs Today
  • Home
  • Islamabad
  • Karachi
  • Lahore
  • National
  • Transfers and Postings
  • Chambers & Associations
  • Business
No Result
View All Result
Customs Today
  • Home
  • Islamabad
  • Karachi
  • Lahore
  • National
  • Transfers and Postings
  • Chambers & Associations
  • Business
No Result
View All Result
Customs Today
No Result
View All Result
Home Karachi

Appraisement-East writes to DC law branch about Rs 250m ZA Pharma tax evasion case

bySohail Rab
28/01/2015
in Karachi, Latest News
Share on FacebookShare on Twitter

KARACHI: The Research and Development Section of Model Customs Collectorate MCC Appraisement-East has written a letter to Deputy Collector Law Branch regarding getting early dates from Sindh High Court into the hearing of Z A Pharma tax evasion case.

According to details, the R&D Section has detected a tax evasion case against the importer Z A Pharma few months ago and made the contravention report against the importer and sent it to the Collectorate of Customs Adjudication-II for further legal proceedings.

You might also like

PM Shehbaz directs FBR to accelerate tax reforms

10/08/2026

World Bank’s Rs115b Balochistan flood project restructured

10/08/2026

The Collectorate of Customs Adjudication-II has issued show-cause notice against the importer Z A Pharma. On which, the importer moved to Sindh High Court and got stay order against the show-cause notice from the honorable Court.

The sources informed Customs Today that the R&D Section has recently written a letter to Deputy Collector Law Branch to get early hearing date from SHC into the case, so that the case could be decided soon. The sources further disclosed that the R&D authorities concerned would also contact with the Deputy Attorney General for getting the date of hearing into the case.

MCC Appraisement-East has made Contravention Report in the month of October-2014 against importer Z A Pharma on its alleged involvement in tax evasion of Rs25605608 in terms of Customs Duty, Sales Tax, Additional Sales Tax and Income Tax .

The R&D in its Contravention Report stated that the importer was deliberately taking inadmissible advantage of SRO567 (I)/2006 and 551(I)/2008 on import of pharmaceutical raw-material.

It further stated the importer Z A Pharma has attempted to evade Rs595407 in terms of Customs Duty; Rs19309523 in terms of Sales Tax; Rs4082099 in terms of AST and Rs1618579 in terms of Income Tax which makes the total of evaded amount tune to Rs25605608

Tags: ASTR&DSalex taxZ A Pharma

Related Stories

PM Shehbaz directs FBR to accelerate tax reforms

byCT Report
10/08/2026

ISLAMABAD: Prime Minister Shehbaz Sharif has directed the Federal Board of Revenue (FBR) to further accelerate the implementation of ongoing...

World Bank’s Rs115b Balochistan flood project restructured

byCT Report
10/08/2026

QUETTA: The government has restructured a Rs. 115 billion World Bank-funded flood rehabilitation project in Balochistan amid allegations of mismanagement...

BoP set to issue Rs30b shares to Punjab govt in major equity move

byCT Report
10/08/2026

LAHORE: The Bank of Punjab (BoP) has just announced a massive financial move. The bank plans to issue up to...

xr:d:DAFGZLzySpE:597,j:42004660331,t:22112408

Future belongs to entrepreneurs who embrace AI, biotechnology: President ICCI

byCT Report
10/08/2026

ISLAMABAD: President Islamabad Chamber of Commerce and Industry (ICCI), Sardar Tahir Mehmood, has called for a fundamental transformation in Pakistan’s...

Next Post

Govt to spend Rs 3 billion on patwaris' welfare: DCO Multan

  • Terms and Conditions
  • Disclaimer

© 2011 Customs Today -World's first newspaper on customs. Customs Today.

No Result
View All Result
  • Transfers and Postings
  • Latest News
  • Karachi
  • Islamabad
  • Lahore
  • National
  • Chambers & Associations
  • Business
  • About Us

© 2011 Customs Today -World's first newspaper on customs. Customs Today.